Analysis of predictive factors for the outcome of complete lymph node dissection in melanoma patients with metastatic sentinel lymph nodes
- 30 April 2011
- journal article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 64 (4), 655-662
- https://doi.org/10.1016/j.jaad.2010.02.047
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of careClinics in Dermatology, 2009
- Sentinel Node Mapping for Melanoma: Results of Trials and Current ApplicationsSurgical Oncology Clinics of North America, 2007
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- The Amount of Metastatic Melanoma in a Sentinel Lymph Node: Does It Have Prognostic Significance?Annals of Surgical Oncology, 2003
- Clinical Outcome of Stage I/II Melanoma Patients After Selective Sentinel Lymph Node Dissection: Long-Term Follow-Up ResultsJournal of Clinical Oncology, 2003
- A new American Joint Committee on Cancer staging system for cutaneous melanomaCancer, 2000
- Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma PatientsJournal of Clinical Oncology, 1999
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the LimbsNew England Journal of Medicine, 1977